DiNuzzo Private Wealth’s Dyne Therapeutics DYN Stock Holding History

DiNuzzo Private Wealth’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$194	Buy	+12	New	+$276	﹤0.01%	1268

Other funds holding DYN

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

DiNuzzo Private Wealth's DYN Position: Q3 2026 in Review

DiNuzzo Private Wealth opened a new position in Dyne Therapeutics (DYN) in Q3 2026: 12 shares worth $194. The stake represents ﹤0.01% of the portfolio and ranks #1268 among its holdings.

36 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

DiNuzzo Private Wealth held 12 shares of Dyne Therapeutics worth $194 as of Q3 2026.
Dyne Therapeutics was a new DiNuzzo Private Wealth position in Q3 2026.
Dyne Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1268 holding.
36 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.